abstract |
The present invention is an inhibitor of dipeptidyl peptidase IV enzyme (DPP-IV inhibitor), which treats or prevents diseases involving dipeptidyl peptidase IV enzyme, such as diabetes, particularly type II diabetes. The present invention relates to a novel substituted aminopiperidine derivative useful for. The present invention further relates to pharmaceutical compositions comprising a pre-compound and to the use of said compounds and compositions in the prevention or treatment of diseases involving dipeptidyl peptidase IV enzymes. |